News & Events

Dr Mahak Singhal’s research focuses on the mechanisms of vascular homeostasis, which is governed by a layer of endothelial cells that lines our blood vessels. In this context, the scientist...

The American Heart Association has awarded its Excellence Award for Hypertension Research to Dominik Müller from the Max Delbrück Center. He is only the third European to be honored with this distinction from the oldest professional society in the U.S.

As embryos develop, countless molecular mechanisms interact in intricate ways. Markus Mittnenzweig builds computational models to help decipher and predict the complex processes behind cell differentiation and tissue formation. His work could also contribute to preventing disease.

Ester Paolocci is a post doc in the Klussmann lab, where she adapts Fluorescence Resonance Energy Transfer to a high-throughput screening system in an effort to discover a new treatment for severe hypertension. Here, she recommends a memoir about struggles with a deeply flawed father.

Can microbiome science be engaging, entertaining, and educational? Absolutely, as shown by “Biopolis.” In the podcast, Chemist Theda Bartolomaeus and producer Michiel van Poelgeest take listeners on a journey into a hidden universe.

Igor Maciel Souza Silva has been awarded a 2-year Marie Curie fellowship. With his grant, he will investigate the structure of the epidermal growth factor receptor, which contributes to the development of cancer. He hopes the research will lead to safer cancer therapies.

Can an aging immune system be coaxed into responding to vaccination like its’ younger self? In “Nature Aging,” Sebastian Hofer, Katja Simon and colleagues discuss emerging interventions that may boost older adults’ response to vaccines. They are also recruiting volunteers for a clinical trial of their own.

During a week-long course at the Gläsernes Labor, 24 teenagers delved into genetics, immunology, and allergic disease. The course marked the beginning of a new collaboration with the Max Delbrück Center, Charité – Universitätsmedizin Berlin, the German Center for Child and Adolescent Health and others.

Neuroblastoma, a cancer mainly affecting children, is often difficult to treat. A team led by Jan Dörr and Anton Henssen at the Experimental and Clinical Research Center report in “Cancer Discovery,” a potential reason treatment sometimes fails and a new strategy to combat particularly resistant tumors.